We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Adenoid Cystic Carcinoma (ACC), a rare cancer affecting salivary glands and other areas. Understand its symptoms, causes, diagnosis, treatment, and outlook.

Adenoid Cystic Carcinoma (ACC) is a rare type of cancer that primarily affects the salivary glands, but can also develop in other areas of the head and neck, and occasionally in places like the breast, lungs, or skin. It is a slow-growing cancer, but it has a notable tendency to recur even after successful treatment. ACC is a form of adenocarcinoma, meaning it originates in glandular cells. Other names for ACC include cribriform carcinoma and cylindroma.
While considered rare overall, ACC is one of the more common types of salivary gland cancers. In the United States, approximately 1,224 people are diagnosed with ACC each year. Research suggests that abnormal gene mutations might play a role in its development, though more studies are needed to confirm this. ACC appears to affect women slightly more often than men, with about 60% of diagnoses being in women. It most commonly affects individuals between the ages of 40 and 60, with many diagnosed around or after the age of 58.
The symptoms of ACC can vary significantly depending on the specific location where the cancer develops. However, a common initial sign, particularly when it affects the head and neck region, is a hard, painless lump.
Depending on the location, other symptoms might include:
It's important to note that these symptoms can also be caused by many other, less serious conditions. However, any persistent or concerning new symptom should be evaluated by a healthcare professional.
The exact cause of Adenoid Cystic Carcinoma is not fully understood. Researchers are still investigating the underlying mechanisms. Due to its rarity and slow growth, creating cell lines for study has been challenging, and the cancer can behave differently depending on its location in the body.
Currently, there are no known definitive risk factors or lifestyle associations that have been conclusively linked to the development of ACC. Unlike many other cancers, ACC has not been strongly associated with:
This lack of clear causative factors underscores the need for ongoing research into the genetic and molecular underpinnings of ACC.
Diagnosing ACC typically involves a multi-step process:
Your doctor will begin by discussing your medical history, including any symptoms you've been experiencing, and conduct a thorough physical examination. They will pay close attention to the affected area, looking for any lumps or abnormalities.
If cancer is suspected, imaging tests are used to help determine the size, location, and extent of the tumor, and whether it has spread to nearby tissues or lymph nodes. Common imaging techniques include:
A biopsy is the definitive diagnostic test for ACC. It involves removing a small sample of the suspected tumor tissue for examination under a microscope by a pathologist. The method of biopsy depends on the tumor's location:
Pathologists analyze the cells to confirm the presence of ACC and determine its characteristics.
Treatment for ACC is tailored to the individual patient, considering the tumor's location, size, stage, and the patient's overall health. The primary treatment modalities include:
Surgery is often the first line of treatment, especially for localized tumors. The goal is to remove as much of the cancerous tissue as possible while preserving the function of nearby organs and tissues. Depending on the location, this could involve removing parts of salivary glands, nerves, or other structures in the head and neck.
Radiation therapy uses high-energy rays to kill cancer cells or slow their growth. It is frequently used after surgery to eliminate any remaining cancer cells or as a primary treatment if surgery is not feasible. It can also be used to manage symptoms.
Chemotherapy involves using drugs to kill cancer cells. While ACC is generally considered less responsive to chemotherapy than some other cancers, it may be used in cases where the cancer has spread to distant parts of the body or to manage advanced disease. Certain drugs have shown promise in research studies, including targeted therapies and immunotherapies, although more research is ongoing.
These newer forms of treatment focus on specific molecules involved in cancer growth or harness the body's immune system to fight cancer. Research is actively exploring their effectiveness for ACC.
The outlook for individuals with ACC can vary. Because ACC tends to grow slowly and has a high rate of recurrence, long-term monitoring is crucial. Survival rates are often used to describe the outlook:
A 2017 study estimated survival rates for ACC. For example, the 5-year relative survival rate can be quite high, but it tends to decrease over longer periods. It's important to understand that survival rates are statistical averages and do not predict the outcome for any individual. Many factors influence an individual's prognosis.
A significant challenge with ACC is its tendency to recur. Approximately 75% of ACCs come back within 10 years of initial treatment. Therefore, lifelong monitoring by healthcare professionals is typically recommended, even if the cancer is initially cured. Ongoing research aims to improve treatment strategies and enhance survival rates.
It is essential to consult a doctor if you notice any of the following:
Early detection and diagnosis are key to managing ACC effectively. Do not ignore persistent or concerning symptoms.
ACC can be treated, and many people achieve remission. However, due to its high recurrence rate, it often requires long-term management and monitoring. Complete cure is possible for some, but vigilance is necessary.
Yes, ACC can spread (metastasize) to other parts of the body, although it most commonly occurs in the head and neck region. When it spreads, it can affect organs like the lungs, liver, or bones.
ACC is a specific type of cancer that arises from glandular cells, particularly in the salivary glands. While it's one of the more common salivary gland cancers, it has unique characteristics, including its slow growth and high recurrence rate, which differentiate it from other types of salivary gland tumors.
Currently, there are no known lifestyle changes that can definitively prevent ACC, as its causes are not fully understood and it's not strongly linked to common risk factors like smoking or diet.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026